Could this vaccine stop future coronavirus outbreaks?
NCT ID NCT06950177
First seen Nov 05, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This early-stage study tests a new vaccine designed to protect against multiple coronaviruses, including COVID-19 and potential future threats. About 51 healthy adults aged 18-55 will receive two doses to check safety and how well the vaccine triggers an immune response. The goal is to develop a broadly protective vaccine that could prevent severe disease from current and future coronavirus variants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Health System
Durham, North Carolina, 27709, United States
Conditions
Explore the condition pages connected to this study.